Tec inhibitors- A new therapeutic for allergic diseases
Tec inhibitors- A new therapeutic for allergic diseases
批准号:
6608039
负责人:
Yuko Kawakami
金额:
$20.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2004-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The incidence of allergic diseases such as
atopic dermatitis (AD) has been dramatically increasing in the US and other
industrialized countries for the past two decades. We and others have
demonstrated that Tec family protein-tyrosine kinases have crucial roles in the
activation of immune cells elicited by the engagement of antigen receptors or
Fc receptors. As such, these kinases are supposed to play critical roles in the
pathogenesis of AD and other allergic diseases that involve the activation of T
and B lymphocytes, mast cells, and eosinophils. We recently identified a
small-molecule compound, terreic acid (TA), as a selective inhibitor of Tec
family kinases. In addition, we recently established highly efficient
experimental conditions to rapidly induce skin lesions in AD-prone NC/Nga mice.
Using this mouse model, we propose to explore whether TA or related compounds
are therapeutically efficacious as a treatment of AD. Since we have a screening
method for searching for Tec inhibitors whose usefulness has been proven, we
will also expand our search for better compounds.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2332/allergolint.o-07-486
发表时间:
2007-12-01
期刊:
Allergology international : official journal of the Japanese Society of Allergology
影响因子:
--
作者:
[Kawakami, Yuko, Yumoto, Kenji, Kawakami, Toshiaki]
通讯作者:
Kawakami, Toshiaki
Tec inhibitors- A new therapeutic for allergic diseases
-
批准号:6443542
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2002
-
负责人:Yuko Kawakami
-
依托单位:
海外基金